ArticleBlood cancer journal2025

Granulocyte colony-stimulating factor plus venetoclax and azacitidine in newly diagnosed acute myeloid leukemia: a multicenter phase 2 trial.

Huaiyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.